Is VIRP.PA undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of Virbac SA (VIRP.PA) is 389.16 EUR. This VIRP.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 305.50 EUR, the upside of Virbac SA is 27.40%. This means that VIRP.PA is undervalued by 27.40%.
The range of the Intrinsic Value is 258.79 - 781.46 EUR
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 258.79 - 781.46 | 389.16 | 27.4% |
DCF (Growth 10y) | 307.32 - 857.08 | 445.25 | 45.7% |
DCF (EBITDA 5y) | 146.36 - 246.84 | 196.62 | -35.6% |
DCF (EBITDA 10y) | 202.03 - 318.12 | 257.96 | -15.6% |
Fair Value | 1,430.66 - 1,430.66 | 1,430.66 | 368.30% |
P/E | 217.00 - 1,030.08 | 551.08 | 80.4% |
EV/EBITDA | 181.84 - 1,548.25 | 726.25 | 137.7% |
EPV | 298.47 - 393.60 | 346.04 | 13.3% |
DDM - Stable | 697.88 - 2,601.75 | 1,649.82 | 440.0% |
DDM - Multi | 244.16 - 700.60 | 361.26 | 18.3% |
Market Cap (mil) | 2,563.15 |
Beta | 0.52 |
Outstanding shares (mil) | 8.39 |
Enterprise Value (mil) | 2,809.96 |
Market risk premium | 5.82% |
Cost of Equity | 6.86% |
Cost of Debt | 4.25% |
WACC | 6.68% |